158 related articles for article (PubMed ID: 34279209)
1. The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy.
Cervantes CE; Kant S; Atta MG
Drug Metab Lett; 2021; 14(2):97-105. PubMed ID: 34279209
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy, cancer, and cancer drugs.
Izzedine H; Perazella MA
Am J Kidney Dis; 2015 Nov; 66(5):857-68. PubMed ID: 25943718
[TBL] [Abstract][Full Text] [Related]
3. Onco-Nephrology: Cancer, chemotherapy and kidney.
de Francisco ALM; Macía M; Alonso F; García P; Gutierrez E; Quintana LF; Quiroga B; Torregrosa I
Nefrologia (Engl Ed); 2019; 39(5):473-481. PubMed ID: 30929891
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathies and antineoplastic agents.
Grangé S; Coppo P;
Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
[TBL] [Abstract][Full Text] [Related]
6. Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
Hobeika L; Self SE; Velez JC
BMC Nephrol; 2014 Sep; 15():156. PubMed ID: 25267524
[TBL] [Abstract][Full Text] [Related]
7. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
[TBL] [Abstract][Full Text] [Related]
8. Onconephrology: mitigation of renal injury in chemotherapy administration.
Selamet U; Ahdoot RS; Salasnek R; Abdelnour L; Hanna RM
Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):257-266. PubMed ID: 38095483
[TBL] [Abstract][Full Text] [Related]
9. Cabozantinib-induced renal thrombotic microangiopathy.
La Manna G; Baraldi O; Corradetti V; Comai G
Nephrology (Carlton); 2018 Jan; 23(1):96-97. PubMed ID: 29250919
[No Abstract] [Full Text] [Related]
10. Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients.
Izzedine H; Mathian A; Albiges L; Champiat S; Brocheriou I
Eur J Cancer; 2021 May; 149():34-36. PubMed ID: 33819719
[No Abstract] [Full Text] [Related]
11. Onco-nephrology: current concepts and future perspectives.
Kitai Y; Matsubara T; Yanagita M
Jpn J Clin Oncol; 2015 Jul; 45(7):617-28. PubMed ID: 25784734
[TBL] [Abstract][Full Text] [Related]
12. A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke.
Phelan PJ; Liew A; Magee C
Ren Fail; 2009; 31(8):743-4. PubMed ID: 19814643
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer agent-induced nephrotoxicity.
Fukasawa H; Furuya R; Yasuda H; Yamamoto T; Hishida A; Kitagawa M
Anticancer Agents Med Chem; 2014; 14(7):921-7. PubMed ID: 24476314
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
Cortazar FB; Marrone KA; Troxell ML; Ralto KM; Hoenig MP; Brahmer JR; Le DT; Lipson EJ; Glezerman IG; Wolchok J; Cornell LD; Feldman P; Stokes MB; Zapata SA; Hodi FS; Ott PA; Yamashita M; Leaf DE
Kidney Int; 2016 Sep; 90(3):638-47. PubMed ID: 27282937
[TBL] [Abstract][Full Text] [Related]
15. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report.
Liou AA; Skiver BM; Yates E; Persad P; Meyer D; Farland AM; Rocco MV
Am J Kidney Dis; 2019 May; 73(5):615-619. PubMed ID: 30528935
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer.
Jagieła J; Bartnicki P; Rysz J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924827
[TBL] [Abstract][Full Text] [Related]
17. C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy.
Shah H; Chen H; Pan XZ; Metjian A; Brodsky RA; Braunstein EM; Chaturvedi S
Blood Adv; 2022 Dec; 6(23):6071-6074. PubMed ID: 35914225
[No Abstract] [Full Text] [Related]
18. Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.
Hilburg R; Geara AS; Qiu MK; Palmer MB; Chiang EY; Burger RA; Hogan JJ
Clin Nephrol; 2021 Jul; 96(1):51-59. PubMed ID: 33896447
[TBL] [Abstract][Full Text] [Related]
19. [Acute renal failure and cancer treatment].
Rafat C; Garcia H; Grangé S
Rev Prat; 2021 Feb; 71(2):216-222. PubMed ID: 34160987
[TBL] [Abstract][Full Text] [Related]
20. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
Page EE; Little DJ; Vesely SK; George JN
Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
